278 related articles for article (PubMed ID: 34115827)
1. Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity.
Park J; Daniels J; Wartewig T; Ringbloom KG; Martinez-Escala ME; Choi S; Thomas JJ; Doukas PG; Yang J; Snowden C; Law C; Lee Y; Lee K; Zhang Y; Conran C; Tegtmeyer K; Mo SH; Pease DR; Jothishankar B; Kwok PY; Abdulla FR; Pro B; Louissaint A; Boggon TJ; Sosman J; Guitart J; Rao D; Ruland J; Choi J
Blood; 2021 Oct; 138(14):1225-1236. PubMed ID: 34115827
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).
Park J; Yang J; Wenzel AT; Ramachandran A; Lee WJ; Daniels JC; Kim J; Martinez-Escala E; Amankulor N; Pro B; Guitart J; Mendillo ML; Savas JN; Boggon TJ; Choi J
Blood; 2017 Sep; 130(12):1430-1440. PubMed ID: 28694326
[TBL] [Abstract][Full Text] [Related]
3. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.
Damsky WE; Choi J
Curr Treat Options Oncol; 2016 Jul; 17(7):33. PubMed ID: 27262707
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
[TBL] [Abstract][Full Text] [Related]
6. Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome.
Caprini E; Bresin A; Cristofoletti C; Helmer Citterich M; Tocco V; Scala E; Monopoli A; Benucci R; Narducci MG; Russo G
Cell Death Dis; 2018 Dec; 9(12):1178. PubMed ID: 30518749
[TBL] [Abstract][Full Text] [Related]
7. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma.
Gaydosik AM; Queen DS; Trager MH; Akilov OE; Geskin LJ; Fuschiotti P
Blood; 2020 Oct; 136(15):1748-1759. PubMed ID: 32438399
[TBL] [Abstract][Full Text] [Related]
9. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
10. Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas.
Gallardo F; Pujol RM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291756
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract][Full Text] [Related]
12. Non-mycosis fungoides cutaneous lymphomas in a referral center in Taiwan: A retrospective case series and literature review.
Liu KL; Tsai WC; Lee CH
PLoS One; 2020; 15(1):e0228046. PubMed ID: 31978091
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.
Xu J; Huang H; Wang S; Chen Y; Yin X; Zhang X; Zhang Y
Arch Dermatol Res; 2020 Sep; 312(7):513-525. PubMed ID: 31676945
[TBL] [Abstract][Full Text] [Related]
14. CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma.
Laharanne E; Chevret E; Idrissi Y; Gentil C; Longy M; Ferrer J; Dubus P; Jouary T; Vergier B; Beylot-Barry M; Merlio JP
Mod Pathol; 2010 Apr; 23(4):547-58. PubMed ID: 20118908
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.
Bakels V; van Oostveen JW; van der Putte SC; Meijer CJ; Willemze R
Am J Pathol; 1997 Jun; 150(6):1941-9. PubMed ID: 9176388
[TBL] [Abstract][Full Text] [Related]
17. Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma.
Iyer A; Hennessey D; O'Keefe S; Patterson J; Wang W; Wong GK; Gniadecki R
Blood Adv; 2020 Jun; 4(11):2489-2500. PubMed ID: 32502269
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
Stoll JR; Willner J; Oh Y; Pulitzer M; Moskowitz A; Horwitz S; Myskowski P; Noor SJ
J Am Acad Dermatol; 2021 Nov; 85(5):1073-1090. PubMed ID: 33940098
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
